Pulmonxcorp Stock Filter Stocks by Fundamentals
LUNG Stock | USD 9.00 0.05 0.55% |
PulmonxCorp fundamentals help investors to digest information that contributes to PulmonxCorp's financial success or failures. It also enables traders to predict the movement of PulmonxCorp Stock. The fundamental analysis module provides a way to measure PulmonxCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PulmonxCorp stock.
PulmonxCorp | Shares Owned by Institutions |
PulmonxCorp Current Valuation Drivers
We derive many important indicators used in calculating different scores of PulmonxCorp from analyzing PulmonxCorp's financial statements. These drivers represent accounts that assess PulmonxCorp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PulmonxCorp's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 1.4B | 2.5B | 1.2B | 312.7M | 484.2M | 460.0M | |
Enterprise Value | 1.4B | 2.3B | 1.0B | 235.4M | 441.8M | 419.7M |
PulmonxCorp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PulmonxCorp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PulmonxCorp's managers, analysts, and investors.Environmental | Governance | Social |
PulmonxCorp Institutional Holders
Institutional Holdings refers to the ownership stake in PulmonxCorp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of PulmonxCorp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PulmonxCorp's value.Shares | Franklin Resources Inc | 2023-12-31 | 742.4 K | Rock Springs Capital Management Lp | 2023-12-31 | 652.4 K | Deutsche Bank Ag | 2023-12-31 | 524.7 K | Goldman Sachs Group Inc | 2023-12-31 | 504.8 K | Pura Vida Investments, Llc | 2023-12-31 | 477.4 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 384.8 K | Norges Bank | 2023-12-31 | 376.9 K | Lord, Abbett & Co Llc | 2023-12-31 | 365.5 K | Northern Trust Corp | 2023-12-31 | 335.3 K | Primecap Management Company | 2023-12-31 | 5.6 M | Fmr Inc | 2023-12-31 | 3.3 M |
PulmonxCorp Fundamentals
Return On Equity | -0.46 | ||||
Return On Asset | -0.21 | ||||
Profit Margin | (0.80) % | ||||
Operating Margin | (0.77) % | ||||
Current Valuation | 273.78 M | ||||
Shares Outstanding | 38.82 M | ||||
Shares Owned By Insiders | 4.99 % | ||||
Shares Owned By Institutions | 95.74 % | ||||
Number Of Shares Shorted | 1.41 M | ||||
Price To Book | 2.59 X | ||||
Price To Sales | 4.46 X | ||||
Revenue | 68.67 M | ||||
Gross Profit | 39.87 M | ||||
EBITDA | (59.99 M) | ||||
Net Income | (60.84 M) | ||||
Cash And Equivalents | 162.09 M | ||||
Cash Per Share | 4.35 X | ||||
Total Debt | 41.42 M | ||||
Debt To Equity | 0.15 % | ||||
Current Ratio | 9.43 X | ||||
Book Value Per Share | 2.85 X | ||||
Cash Flow From Operations | (37.61 M) | ||||
Short Ratio | 2.68 X | ||||
Earnings Per Share | (1.54) X | ||||
Price To Earnings To Growth | (0.42) X | ||||
Target Price | 15.4 | ||||
Number Of Employees | 279 | ||||
Beta | 0.67 | ||||
Market Capitalization | 349.34 M | ||||
Total Asset | 178.95 M | ||||
Retained Earnings | (411.16 M) | ||||
Working Capital | 127.27 M | ||||
Net Asset | 178.95 M |
About PulmonxCorp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PulmonxCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PulmonxCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PulmonxCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether PulmonxCorp is a strong investment it is important to analyze PulmonxCorp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PulmonxCorp's future performance. For an informed investment choice regarding PulmonxCorp Stock, refer to the following important reports:Check out PulmonxCorp Piotroski F Score and PulmonxCorp Altman Z Score analysis. For more detail on how to invest in PulmonxCorp Stock please use our How to Invest in PulmonxCorp guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for PulmonxCorp Stock analysis
When running PulmonxCorp's price analysis, check to measure PulmonxCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PulmonxCorp is operating at the current time. Most of PulmonxCorp's value examination focuses on studying past and present price action to predict the probability of PulmonxCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PulmonxCorp's price. Additionally, you may evaluate how the addition of PulmonxCorp to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is PulmonxCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PulmonxCorp. If investors know PulmonxCorp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PulmonxCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share 1.909 | Quarterly Revenue Growth 0.297 | Return On Assets (0.21) | Return On Equity (0.46) |
The market value of PulmonxCorp is measured differently than its book value, which is the value of PulmonxCorp that is recorded on the company's balance sheet. Investors also form their own opinion of PulmonxCorp's value that differs from its market value or its book value, called intrinsic value, which is PulmonxCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PulmonxCorp's market value can be influenced by many factors that don't directly affect PulmonxCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PulmonxCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if PulmonxCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PulmonxCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.